-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
35%RNA,、
——
,,
Alternative splicing (AS, also known as alternative splicing) is a general regulation mechanism of gene expression in eukaryotes.
Taking phosphatase and actin regulatory factor 1 (PHACTR1) as an example, this gene was determined to be related to human coronary artery disease (CAD) in 2009 [9]
In addition, the horse COBLL1 gene has two alternative splicing, COBLL1a and COBLL1b with exon 9 deletion
The above two examples both illustrate that through alternative splicing, the same gene can perform different biological functions
The correct analysis of functional gene expression is first based on the researchers' comprehensive understanding of the alternative splicing of the target gene
Tiosbio has focused on the RNA field for 12 years.
Request details of Tiosbio SUPERSWITCH RACE cDNA Synthesis Kit now
references
[1].